Does RISANKIZUMAB-RZAA Cause Multiple sclerosis? 109 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 109 reports of Multiple sclerosis have been filed in association with RISANKIZUMAB-RZAA. This represents 0.2% of all adverse event reports for RISANKIZUMAB-RZAA.
109
Reports of Multiple sclerosis with RISANKIZUMAB-RZAA
0.2%
of all RISANKIZUMAB-RZAA reports
0
Deaths
8
Hospitalizations
How Dangerous Is Multiple sclerosis From RISANKIZUMAB-RZAA?
Of the 109 reports, 8 (7.3%) required hospitalization.
Is Multiple sclerosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 109 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Multiple sclerosis?
DIMETHYL (5,074)
NATALIZUMAB (4,078)
INTERFERON BETA-1A (3,412)
OCRELIZUMAB (2,609)
GLATIRAMER (2,596)
DALFAMPRIDINE (2,224)
FINGOLIMOD (2,123)
TERIFLUNOMIDE (1,983)
OFATUMUMAB (1,267)
DIROXIMEL (978)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Multiple sclerosis Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA